Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Wang, Jia; Cheng, Peng; Pavlyukov, Marat S; Yu, Hai; Zhang, Zhuo; Kim, Sung-Hak; Minata, Mutsuko; Mohyeldin, Ahmed; Xie, Wanfu; Chen, Dongquan; Goidts, Violaine; Frett, Brendan; Hu, Wenhao; Li, Hongyu; Shin, Yong Jae; Lee, Yeri; Nam, Do-Hyun; Kornblum, Harley I; Wang, Maode; Nakano, Ichiro

Wang, Jia; Cheng, Peng; Pavlyukov, Marat S; Yu, Hai; Zhang, Zhuo; Kim, Sung-Hak; Minata, Mutsuko; Mohyeldin, Ahmed; Xie, Wanfu; Chen, Dongquan; Goidts, Violaine; Frett, Brendan; Hu, Wenhao; Li, Hongyu; Shin, Yong Jae; Lee, Yeri; Nam, Do-Hyun; Kornblum, Harley I; Wang, Maode; Nakano, Ichiro.

J Clin Invest ; 130(11): 6187, 2020 11 02.

Article en En | MEDLINE | ID: mdl-33044225

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598038
https://dx.doi.org/10.1172/JCI144618

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Invest Año: 2020 Tipo del documento: Article